
    
      It is anticipated that a majority of subjects will require and receive a single treatment;
      however, those subjects not showing improvement at the follow-up visit 2 weeks after initial
      treatment will be treated a second time. Those subjects originally assigned to vehicle for
      the first treatment will receive a "re-treatment" with one of the active doses.
    
  